We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$202M
AUM Growth
+$19M
Cap. Flow
+$23.8M
Cap. Flow %
11.8%
Top 10 Hldgs %
29.52%
Holding
189
New
37
Increased
84
Reduced
33
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 22.94%
2 Technology 8.76%
3 Consumer Discretionary 6.47%
4 Energy 6.3%
5 Consumer Staples 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOMX
176
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$103K 0.05%
34,000
VVR icon
177
Invesco Senior Income Trust
VVR
$460M
$86K 0.04%
20,500
+2,200
+12% +$9.23K
DHF
178
BNY Mellon High Yield Strategies Fund
DHF
$175M
$79K 0.04%
25,900
+900
+4% +$2.76K
CCXI
179
DELISTED
ChemoCentryx, Inc.
CCXI
$68K 0.03%
10,000
OVV icon
180
Ovintiv
OVV
$17.6B
$52K 0.03%
2,270
-2,057
-48% -$47.1K
ALGN icon
181
Align Technology
ALGN
$12.3B
-1,000
Closed -$274K
BFH icon
182
Bread Financial
BFH
$4.36B
-2,431
Closed -$272K
BOND icon
183
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.46B
-2,119
Closed -$228K
DES icon
184
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
-7,928
Closed -$215K
JAZZ icon
185
Jazz Pharmaceuticals
JAZZ
$16.1B
-1,605
Closed -$229K
SLYG icon
186
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.2B
-3,757
Closed -$229K
TSCO icon
187
Tractor Supply
TSCO
$18.4B
-10,000
Closed -$218K
CELG
188
DELISTED
Celgene Corp
CELG
-2,925
Closed -$270K
PLM
189
DELISTED
PolyMet Mining Corp.
PLM
-2,000
Closed -$9K

Similar funds

Fernwood Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Fernwood Investment Management held 189 positions worth $202M, up 10% from $183M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Fernwood Investment Management deployed $23.8M of net new capital in Q3 2019, opening 37 new positions and adding to 84 existing holdings. Its largest new stake was BridgeBio Pharma: 95,200 shares worth $2.04M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was MyoKardia, Inc. Common Stock, an estimated $606K trimmed.

  • Fernwood Investment Management's largest Q3 2019 buy was BridgeBio Pharma: 95,200 shares worth $2.04M.
  • Fernwood Investment Management added most to Apple in Q3 2019, an estimated $798K increase.
  • Fernwood Investment Management's biggest Q3 2019 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $606K.
  • Fernwood Investment Management fully exited Align Technology in Q3 2019, selling an estimated $274K.
  • Fernwood Investment Management's ten largest holdings make up 30% of its $202M portfolio in Q3 2019.
  • Fernwood Investment Management opened 37 new positions and closed 9 in Q3 2019.
  • Fernwood Investment Management's portfolio value rose 10% quarter-over-quarter to $202M.

Based on Fernwood Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.